Live Activities
Dopamine Transporter Imaging in Neurological Practice

Dopamine Transporter Imaging in Neurological Practice

Workshop Location

Workshop Venue
l'Institut du Cerveau et de la Moelle épinière (ICM)

Hôpital Pitié Salpêtrière
47, boulevard de l'Hôpital
Paris, 75013


+33 (0)1 57 27 40 00

December 10, 2010
Paris, France

Course Description

This workshop intended to introduce participants to the potential of dopamine transporter single photon emission computed tomography (SPECT) imaging in neurological practice. The workshop answered some common questions, such as when it is appropriate for dopamine transporter imaging to be ordered by general practitioners, neurologists or Movement Disorders specialists. While some questions can be answered by a number of published dopamine transporter imaging studies of high scientific standard, answers to other questions are highly dependent upon expert opinion. The goal of the workshop was to present a balanced view of the currently available information on dopamine transporter imaging studies. The scope of information presented and discussed had been chosen to not only identify the potential usefulness of dopamine transporter imaging in neurological practice, but also to guard against indiscriminate and injudicious use of dopamine transporter imaging or erroneous interpretation of findings.

Learning Objectives

At the conclusion of the activity, participants should be able to:

  • Describe how dopamine transporter imaging is performed and discuss the science underlying the procedure
  • Discuss the interpretation of dopamine transporter images
  • List the diseases/symptoms for which dopamine transporter imaging may be an appropriate investigative tool
  • Discuss how patients suitable for this procedure would be identified
  • Discuss the current uses, potential future uses, and limitations of dopamine transporter imaging in neurological clinical practice and research applications

Recommended Audience

This course is recommended for specialists or trainees in Movement Disorders and general neurologists.


Supported in part by an educational grant from:
GE Healthcare